Developing a systems approach to prevent meconium aspiration syndrome: lessons learned from multinational studies

Area of Science:

• Neonatal Medicine
• Perinatal Care
• Respiratory Physiology

Background:

• Meconium-stained amniotic fluid (MSAF) occurs in about 1 in 6 births and can indicate fetal distress.
• Meconium aspiration syndrome (MAS) is a significant cause of neonatal morbidity and mortality.
• Advanced treatments like ECMO, HFOV, and iNO have improved outcomes but are costly and not universally accessible.

Purpose of the Study:

• To describe a systems-approach for prenatal, natal, and postnatal management of MSAF.
• To minimize adverse outcomes and reduce the need for innovative ventilatory support in neonates exposed to MSAF.
• To assess evidence for pivotal steps in preventing MAS and related neonatal complications.

Main Methods:

• Analysis of data from a single urban perinatal center (1995-2000) on MSAF incidence and MAS outcomes.
• Evaluation of a coordinated, systems-based approach to prenatal, natal, and postnatal care.
• Review of evidence for key interventions in MAS prevention and management.

Main Results:

• MSAF occurred in 14.5% of live births, with 4.6% developing MAS.
• 26% of MAS infants required ventilatory support, and only 0.035% needed innovative support.
• No MAS infants in the study died or required ECMO.

Conclusions:

• A systems-approach to MSAF management can effectively prevent MAS and reduce the need for advanced respiratory support.
• This strategy is cost-effective and safer for neonates at risk for MAS-related respiratory failure.
• Replication of this approach in diverse perinatal settings can improve neonatal outcomes.